Results 21 to 30 of about 8,067,684 (279)

Agent-based simulation of open source evolution [PDF]

open access: yes, 2006
We present an agent-based simulation model developed to study how size, complexity and effort relate to each other in the development of open source software (OSS).
Abdel-Hamid   +39 more
core   +1 more source

Open Source

open access: yesEm Tese, 2018
The phrase “open source” is not something often heard in everyday conversation. However, the idea of downloadable, free, software, particularly mobile applications, or “apps,” has become quite commonplace. Individuals often download free products, grateful that they are available, and will potentially work well, without thinking where they originate or
Ronnie Lessem, Tony Bradley
  +5 more sources

QSAR-based models for designing quinazoline/imidazothiazoles/pyrazolopyrimidines based inhibitors against wild and mutant EGFR. [PDF]

open access: yesPLoS ONE, 2014
Overexpression of EGFR is responsible for causing a number of cancers, including lung cancer as it activates various downstream signaling pathways. Thus, it is important to control EGFR function in order to treat the cancer patients.
Jagat Singh Chauhan   +5 more
doaj   +1 more source

Open Source for Open Source License Compliance

open access: yes, 2019
Today, many software systems are of a level of complexity that no single company can implement modern solutions alone. Thus many companies engage in the open source software (OSS) ecosystem to keep the development costs manageable. But the usage of third-party components (both OSS and commercial) also mandates the need of a license compliance process ...
Fendt, Oliver, Jaeger, Michael
openaire   +1 more source

Open Source in libraries [PDF]

open access: yes, 2006
Author presents his opinions about open source software, explains possible mistakes and obstacles as well as good sides of such a software.
Lease Morgan, Eric
core  

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

ESPEE: Event-Based Sensor Pose Estimation Using an Extended Kalman Filter

open access: yesSensors, 2021
Event-based vision sensors show great promise for use in embedded applications requiring low-latency passive sensing at a low computational cost. In this paper, we present an event-based algorithm that relies on an Extended Kalman Filter for 6-Degree of ...
Fabien Colonnier   +2 more
doaj   +1 more source

Why and When Are Evidence‐Based Interventions Adopted in Paediatric Supportive Care? A Qualitative Exploration of the Determinants of Photobiomodulation Implementation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Oral mucositis is a common and debilitating side effect of childhood cancer and stem cell transplant treatments. It affects the quality of life of children and young people (CYP) and places a strain on services. Photobiomodulation is recommended for oral mucositis prevention in international guidance but is poorly implemented in UK ...
Claudia Heggie   +4 more
wiley   +1 more source

Measuring and mitigating debugging effectiveness decay in code language models

open access: yesScientific Reports
The effectiveness of AI debugging follows a predictable exponential decay pattern; most models lose 60-80% of their debugging capability within just 2-3 attempts, despite iterative debugging being a critical capability for practical code generation ...
Muntasir Adnan, Carlos C. N. Kuhn
doaj   +1 more source

Resources, challenges and way forward in rare mitochondrial diseases research [v2; ref status: indexed, http://f1000r.es/5r6]

open access: yesF1000Research, 2015
Over 300 million people are affected by about 7000 rare diseases globally. There are tremendous resource limitations and challenges in driving research and drug development for rare diseases.
Neeraj Kumar Rajput   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy